5-Methyl-2-(3-trifluoromethylbenzyl)-2H-pyrazol-3-ylamine, >95%, 1g

N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, 95.0%, 25g

2,2,2-Trifluoro-1-(pyridin-3-yl)ethanone, 95%, 250mg

Dimethyl 2-(2-nitro-4-(trifluoromethyl)phenyl)malonate, 95.0%, 1g

1-Methyl-6-nitro-1H-indole, 95.0%, 1g

3-Bromo-6-fluoro-1H-indole-5-carbonitrile, 98%, 5g

n-pentano, mínimo 99 %, para síntesis, 2,5 l, envase de vidrio

(S)-2-Acetamidosuccinic acid, 95.0%, 5g

1-Pyridin-2-ylmethylpiperidin-4-one, 95.0%, 2.5g

Solución de tetraóxido de osmio

1-(2-Methoxy-6-((4-methoxybenzyl)oxy)phenyl)ethanone, 95.0%, 1g

Calcium 4-methyl-2-oxopentanoate, 95.0%, 1g

4'-Ethoxyphenyl acetylene, 97.0%, 5g